NextCell Pharma AB

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009723125
SEK
1.24
0.01 (1.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
NextCell Pharma AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Aug'25
Aug'24
Aug'23
Aug'22
Aug'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-50.00
-35.00
-41.00
-39.00
-34.00
-24.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-3.00
-6.00
3.00
-4.00
0.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-50.00
-38.00
-37.00
-43.00
-33.00
-25.00
Cash Flow from Investing Activities
-5.00
-4.00
0.00
-4.00
-9.00
-5.00
Cash Flow from Financing Activities
35.00
35.00
34.00
0.00
0.00
148.00
Net Cash Inflow / Outflow
-20.00
-8.00
-3.00
-47.00
-42.00
117.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of NextCell Pharma AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
-50.933641
-26.266
-24.00
-93.91%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-3.324085
12.374
-15.00
-126.86%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-50.899165
-13.03
-37.00
-290.63%
Cash Flow from Investing Activities
-5.265957
-26.552
21.00
80.17%
Cash Flow from Financing Activities
35.408151
24.405
11.00
45.09%
Net Cash Inflow / Outflow
-20.75697
-15.177
-5.00
-36.77%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

Not Applicable: The company has declared_date for only one period

Dec'25
Change(%)
Cash Flow from Operating Activities
-50.90
NA
NA